did anyone actually listen to the call? I slept through it. It sounds like we are completely screwed....aplindore, despite showing statiscally significant results at the lowest dose, is apparently worthless. Davis is not a very good salesman. Neurogen should terminate the Ligand deal but it sounds like they are just going to give the company away to them (literally because at current LGND prices they would pay less than $8M in stock to get over $8M in cash alone).

This is a complete train wreck. We all should have dumped this POS in June when it hit $0.45